Response:: The hyper IgE and mutations syndrome in TYK2

被引：0
|
作者：
Minegishi, Yoshiyuki [1 ]
Saito, Masako [1 ]
Karasuyama, Hajime [1 ]
机构：
[1] Tokyo Med & Dent Univ, Dept Immune Regulat, Grad Sch, Bunkyo Ku, Tokyo 1138519, Japan
来源：
IMMUNITY | 2007年 / 26卷 / 05期
关键词：
D O I：
10.1016/j.immuni.2007.05.008
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：536 / 536
页数：1
相关论文
共 50 条
  • [21] STAT3 mutations in the hyper-IgE syndrome
    Holland, Steven M.
    Deleo, Frank R.
    Elloumi, Houda Z.
    Hsu, Amy P.
    Uzel, Gulbu
    Brodsky, Nina
    Freeman, Alexandra F.
    Demidowich, Andrew
    Davis, Joie
    Turner, Maria L.
    Anderson, Victoria L.
    Darnell, Dirk N.
    Welch, Pamela A.
    Kuhns, Douglas B.
    Frucht, David M.
    Malech, Harry L.
    Gallin, John I.
    Kobayashi, Scott D.
    Whitney, Adeline R.
    Voyich, Jovanka M.
    Musser, James M.
    Woellner, Cristina
    Schaeffer, Alejandro A.
    Puck, Jennifer M.
    Grimbacher, Bodo
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1608 - 1619
  • [22] Targeting the Tyrosine Kinase 2 (TYK2) Pseudokinase Domain: Discovery of the Selective TYK2 Inhibitor ABBV-712
    Breinlinger, Eric
    Van Epps, Stacy
    Friedman, Michael
    Argiriadi, Maria
    Chien, Ellen
    Chhor, Gekleng
    Cowart, Marlon
    Dunstan, Theresa
    Graff, Candace
    Hardee, David
    Herold, J. Martin
    Little, Andrew
    Mccarthy, Richard
    Parmentier, Julie
    Perham, Matthew
    Qiu, Wei
    Schrimpf, Michael
    Vargo, Thomas
    Webster, Matthew P.
    Wu, Fei
    Bennett, Dawn
    Edmunds, Jeremy
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (20) : 14335 - 14356
  • [23] TYK2 as a novel therapeutic target in psoriasis
    Elyoussfi, Sarah
    Rane, Shraddha S.
    Eyre, Steve
    Warren, Richard B.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (06) : 549 - 558
  • [24] TYK2: An Upstream Kinase of STATs in Cancer
    Woess, Katharina
    Simonovic, Natalija
    Strobl, Birgit
    Macho-Maschler, Sabine
    Mueller, Mathias
    CANCERS, 2019, 11 (11)
  • [25] A New Patient with Inherited TYK2 Deficiency
    Sarrafzadeh, Shokouh Azam
    Mahloojirad, Maryam
    Casanova, Jean-Laurent
    Badalzadeh, Mohsen
    Bustamante, Jacinta
    Boisson-Dupuis, Stephanie
    Pourpak, Zahra
    Nourizadeh, Maryam
    Moin, Mostafa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (01) : 232 - 235
  • [26] TYK2 in Immune Responses and Treatment of Psoriasis
    Shang, Lin
    Cao, Jiali
    Zhao, Siqi
    Zhang, Jingya
    He, Yanling
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 5373 - 5385
  • [27] Tyk2 is a tumor suppressor in colorectal cancer
    Moritsch, Stefan
    Moedl, Bernadette
    Scharf, Irene
    Janker, Lukas
    Zwolanek, Daniela
    Timelthaler, Gerald
    Casanova, Emilio
    Sibilia, Maria
    Mohr, Thomas
    Kenner, Lukas
    Herndler-Brandstetter, Dietmar
    Gerner, Christopher
    Mueller, Mathias
    Strobl, Birgit
    Eferl, Robert
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [28] Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia
    Michiko Nemoto
    Hiroyoshi Hattori
    Naoko Maeda
    Nobuhiro Akita
    Hideki Muramatsu
    Suzuko Moritani
    Tomonori Kawasaki
    Masami Maejima
    Hirotaka Ode
    Atsuko Hachiya
    Wataru Sugiura
    Yoshiyuki Yokomaku
    Keizo Horibe
    Yasumasa Iwatani
    Scientific Reports, 8
  • [29] Lead optimization of a TYK2 selective scaffold
    Liang, Jun
    Magnuson, Steve
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [30] Identification of a TYK2 selective lead series
    Magnuson, Steven
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
12345